Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Targeted Anticancer Therapies Congress 2025

Hurdles in the regulatory and operational framework of early drug development in Europe

Optimising the EU Clinical Trial Regulation and the Clinical Trials Information System to increase the attractiveness of the EU as a destination for clinical trials

Date

04 Mar 2025

Session

Hurdles in the regulatory and operational framework of early drug development in Europe

Topics

Cancer Research

Tumour Site

Presenters

Martin O'Kane

Authors

M. O'Kane

Author affiliations

  • Novartis Pharmaceuticals UK Limited, W12 7FQ - London/GB

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Panel discussion

Session: Hurdles in the regulatory and operational framework of early drug development in Europe

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.